News | February 26, 2015

Increasing incidence of cancers, replacement of older radiotherapy systems driving demand in U.S., abroad

February 26, 2015 — MarketReportsOnline.com adds "Global Radiation Therapy Market Report: 2015 Edition" report that says worldwide radiation therapy market has shown significant growth over the past few years, with North America as the highly competitive and largest market for radiotherapy devices.

Europe is the second largest consumer of radiotherapy devices market. Although demand for radiotherapy devices slowed down in Europe in 2012, the region picked up in 2013. On the other hand, Asia Pacific's radiotherapy market has enjoyed a tremendous growth rate during last few years. As per the report "Global Radiation Therapy Market: 2015 Edition", the proton therapy market posed a very strong growth and will continue for the foreseeable future. It also indicates that the demand for proton beam therapy will be high in the future thereby resulting in increasing expenditure on radiotherapy treatment. Moreover, the increasing number of cancer patients, rapid change in cancer treatment technology and emerging healthy reimbursement plans will continue to enhance the demand for radiotherapy equipments and products.

Radiotherapy is a treatment procedure that involves the use of high-energy radiation. Nowadays, new treatment techniques such as image guided radiation therapy (IGRT), proton therapy; brachytherapy and stereotactic radiation therapy are being increasingly adopted. Moreover, due to the less risk in proton therapy treatment, it has become the most preferred option for treating cancer. Further, it is projected that the IGRT market will grow at a stronger pace than the overall radiation therapy market as it reduces the long-term treatment side effects.

The United States is the largest market of radiotherapy devices globally. The U.S. market growth is mainly driven by the increasing incidence of cancers, replacements of older radiotherapy systems and reimbursement levels for radiation therapy.

Demand for radiotherapy devices in the Asia Pacific region has shown significant growth, mainly driven by China. The key factors driving the growth of the radiation therapy market include higher incidence of cancer, rising healthcare expenditures, rise in aging population and steady rise in global gross domestic product (GDP). The major issues faced by the market include stringent regulations and expensive treatments.

The increasing competition in the radiotherapy market has been analyzed on number of factors: proton therapy market, installed base and new orders. The report presents some of the major drivers, trends and challenges being faced by the market. It also discusses the company profiles of the top four players in the radiation therapy market:  Varian, Siemens, Elekta and Accuray.

For more information: www.marketreportsonline.com


Related Content

News | Prostate Cancer

September 22, 2023 — According to an accepted manuscript published in the American Journal of Roentgenology (AJR) ...

Time September 22, 2023
arrow
Feature | Radiation Oncology

The radiation oncology community lost a leader this past summer, with the passing of Jay Loeffler, MD, FACR, FASTRO. He ...

Time September 21, 2023
arrow
Feature | Proton Therapy | By Christine Book

An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of ...

Time September 21, 2023
arrow
News | Radiation Therapy

September 20, 2023 — RefleXion Medical, Inc., a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a ...

Time September 20, 2023
arrow
News | Radiation Oncology

September 6, 2023 — Nina D’Abreo, MD, has been named as chief of the Division of Hematology and Medical Oncology at NYU ...

Time September 06, 2023
arrow
News | Radiation Oncology

August 30, 2023 — Elekta and the IAEA have signed a partnership agreement to jointly pursue common interests, including ...

Time August 30, 2023
arrow
News | Radiopharmaceuticals and Tracers

August 28, 2023 — TerraPower Isotopes and PanTera, the Belgian joint venture created by SCK CEN and IBA, announced that ...

Time August 28, 2023
arrow
News | Radiology Business

July 27, 2023 — Privately-held biotech company TAE Life Sciences has announced that its board of directors has appointed ...

Time July 27, 2023
arrow
News | Prostate Cancer

July 24, 2023 — A technique that uses imaging technology as a guide can make radiation therapy safer for patients with ...

Time July 24, 2023
arrow
News | Oncology Information Management Systems (OIMS)

July 21, 2023 — A key feature of RayCare 2023B is the enhanced fully integrated management of radiotherapy treatment ...

Time July 21, 2023
arrow
Subscribe Now